“…We believe that EGCG is a candidate phytochemical. A large number of studies have demonstrated that EGCG could affect the expression of specific proteins and signal pathways, such as AMPK and related pathways [ 28 , 30 , [60] , [61] , [62] ], and intervene in a variety of RCD forms, such as autophagy, apoptosis, and ferroptosis [ [34] , [35] , [36] , [63] , [64] , [65] ], all of which confirm its pharmacological characteristics, multiple targets, and underlying mechanisms [ 24 , 25 ]. Our results revealed that in DIC, EGCG pretreatment effectively decreased iron accumulation, inhibited excess ROS generation and oxidative stress, and rectified abnormal lipid metabolism in vitro and in vivo, which was similar to the intervention effects of the ferroptosis inhibitor Fer-1 [ 19 , 20 ], iron chelator Dxz [ 52 , 58 ], and mitochondrial free radical scavenger MitoTEMPO [ 18 , 19 ].…”